Pat Nasshorn

Pat Nasshorn is an experienced business executive with a strong background in business strategy and international business development. Currently serving as Chief Business Officer at FreeOx Biotech since November 2024 and operating as a self-employed Business Development Executive since January 2024, Pat has held significant roles in the biopharmaceutical industry, including Chief Business Officer at Cue Biopharma from December 2021 to December 2023. Previous experience includes a long tenure as a self-employed Business Development Executive from June 2015 to November 2021 and as CEO of AposTherapy from October 2013 to May 2015. Pat holds an MBA in Marketing and Finance from the Fox School of Business at Temple University.